0000950170-24-062585.txt : 20240520
0000950170-24-062585.hdr.sgml : 20240520
20240520183026
ACCESSION NUMBER: 0000950170-24-062585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240520
DATE AS OF CHANGE: 20240520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bair Teresa Brophy
CENTRAL INDEX KEY: 0001813058
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37620
FILM NUMBER: 24966386
MAIL ADDRESS:
STREET 1: C/O KURA ONCOLOGY, INC.
STREET 2: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kura Oncology, Inc.
CENTRAL INDEX KEY: 0001422143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 611547851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 500-8800
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE, SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: ZETA ACQUISITION CORP III
DATE OF NAME CHANGE: 20071227
4
1
ownership.xml
4
X0508
4
2024-05-20
0001422143
Kura Oncology, Inc.
KURA
0001813058
Bair Teresa Brophy
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400
SAN DIEGO
CA
92130
false
true
false
false
Chief Legal Officer
true
Common Stock
2024-05-20
4
S
false
2615
22.1477
D
68979
D
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.
2615 shares were acquired on May 17, 2024 pursuant to the Issuer's Employee Stock Purchase Plan.
This transaction was executed in multiple trades at prices ranging from $22.06 to $22.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The reported sale of 2,615 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 22, 2023.
/s/ Teresa Bair
2024-05-20